Atorvastatin reduces inflammatory markers like CRP in cardiovascular diseases, potentially lessening chronic inflammation and thereby reducing future cardiac risks.

Atorvastatin has been shown to lower levels of C-reactive protein and other inflammatory markers, which may decrease the risk of cardiovascular events in patients with chronic inflammation.